drugset / Trial / NCT00887406
Study of GSK961081 in Healthy Volunteer Subjects
RandomizedCrossoverDouble-blindTreatment
Summary
GSK961081 is a new long-acting bronchodilator being developed for the treatment of chronic obstructive pulmonary disease (COPD). This study is the first clinical study in humans. The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics of GSK961081 in healthy male subjects.
Timeline
- Start
- 2005-11-07
- Primary completion
- 2006-10-04
- Completion
- 2006-10-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Batefenterol | Small molecule | 3 ug | Other |
| Subject | Batefenterol | Small molecule | 15 ug | Other |
| Subject | Batefenterol | Small molecule | 50 ug | Other |
| Subject | Batefenterol | Small molecule | 100 ug | Other |
| Subject | Batefenterol | Small molecule | 200 ug | Other |
| Subject | Batefenterol | Small molecule | 300 ug | Other |